PROVECTUS PHARMACEUTICALS INC 4
4 · PROVECTUS PHARMACEUTICALS INC · Filed Sep 24, 2013
Insider Transaction Report
Form 4
Koe Jan
Director
Transactions
- Purchase
Common Stock
2013-09-20+100,000→ 586,300 total - Purchase
Common Stock Warrants (right to buy)
2013-09-20+150,000→ 150,000 totalExercise: $1.00From: 2013-09-20Exp: 2018-09-20→ Common Stock (150,000 underlying)
Holdings
- 150,000(indirect: By LLC)
Common Stock
Footnotes (2)
- [F1]The reported securities were purchased together, such that the purchase price for each share of common stock together with a warrant to purchase one and one-half shares of common stock is $0.75.
- [F2]The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.